• Je něco špatně v tomto záznamu ?

Ovariectomy-Induced Hepatic Lipid and Cytochrome P450 Dysmetabolism Precedes Serum Dyslipidemia

H. Malinská, M. Hüttl, D. Miklánková, J. Trnovská, I. Zapletalová, M. Poruba, I. Marková

. 2021 ; 22 (9) : . [pub] 20210426

Jazyk angličtina Země Švýcarsko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc21018782

Grantová podpora
IKEM, IN 00023001 Ministry of Health of the Czech Republic under its conceptual development of research organisations programme
NU20-01-00083 Ministry of Health of the Czech Republic
IGA_LF_2021_013. Ministry of Health of the Czech Republic

Ovarian hormone deficiency leads to increased body weight, visceral adiposity, fatty liver and disorders associated with menopausal metabolic syndrome. To better understand the underlying mechanisms of these disorders in their early phases of development, we investigated the effect of ovariectomy on lipid and glucose metabolism. Compared to sham-operated controls, ovariectomized Wistar female rats markedly increased whole body and visceral adipose tissue weight (p ˂ 0.05) and exhibited insulin resistance in peripheral tissues. Severe hepatic triglyceride accumulation (p ˂ 0.001) after ovariectomy preceded changes in both serum lipids and glucose intolerance, reflecting alterations in some CYP proteins. Increased CYP2E1 (p ˂ 0.05) and decreased CYP4A (p ˂ 0.001) after ovariectomy reduced fatty acid oxidation and induced hepatic steatosis. Decreased triglyceride metabolism and secretion from the liver contributed to hepatic triglyceride accumulation in response to ovariectomy. In addition, interscapular brown adipose tissue of ovariectomized rats exhibited decreased fatty acid oxidation (p ˂ 0.01), lipogenesis (p ˂ 0.05) and lipolysis (p ˂ 0.05) despite an increase in tissue weight. The results provide evidence that impaired hepatic triglycerides and dysregulation of some CYP450 proteins may have been involved in the development of hepatic steatosis. The low metabolic activity of brown adipose tissue may have contributed to visceral adiposity as well as triglyceride accumulation during the postmenopausal period.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc21018782
003      
CZ-PrNML
005      
20211207141615.0
007      
ta
008      
210728s2021 sz f 000 0|eng||
009      
AR
024    7_
$a 10.3390/ijms22094527 $2 doi
035    __
$a (PubMed)33926097
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Malinská, Hana $u Centre for Experimental Medicine, Institute for Clinical and Experimental Medicine, 14021 Prague, Czech Republic
245    10
$a Ovariectomy-Induced Hepatic Lipid and Cytochrome P450 Dysmetabolism Precedes Serum Dyslipidemia / $c H. Malinská, M. Hüttl, D. Miklánková, J. Trnovská, I. Zapletalová, M. Poruba, I. Marková
520    9_
$a Ovarian hormone deficiency leads to increased body weight, visceral adiposity, fatty liver and disorders associated with menopausal metabolic syndrome. To better understand the underlying mechanisms of these disorders in their early phases of development, we investigated the effect of ovariectomy on lipid and glucose metabolism. Compared to sham-operated controls, ovariectomized Wistar female rats markedly increased whole body and visceral adipose tissue weight (p ˂ 0.05) and exhibited insulin resistance in peripheral tissues. Severe hepatic triglyceride accumulation (p ˂ 0.001) after ovariectomy preceded changes in both serum lipids and glucose intolerance, reflecting alterations in some CYP proteins. Increased CYP2E1 (p ˂ 0.05) and decreased CYP4A (p ˂ 0.001) after ovariectomy reduced fatty acid oxidation and induced hepatic steatosis. Decreased triglyceride metabolism and secretion from the liver contributed to hepatic triglyceride accumulation in response to ovariectomy. In addition, interscapular brown adipose tissue of ovariectomized rats exhibited decreased fatty acid oxidation (p ˂ 0.01), lipogenesis (p ˂ 0.05) and lipolysis (p ˂ 0.05) despite an increase in tissue weight. The results provide evidence that impaired hepatic triglycerides and dysregulation of some CYP450 proteins may have been involved in the development of hepatic steatosis. The low metabolic activity of brown adipose tissue may have contributed to visceral adiposity as well as triglyceride accumulation during the postmenopausal period.
650    _2
$a hnědá tuková tkáň $x metabolismus $7 D002001
650    _2
$a bílá tuková tkáň $x metabolismus $7 D052436
650    _2
$a zvířata $7 D000818
650    _2
$a systém (enzymů) cytochromů P-450 $x metabolismus $x fyziologie $7 D003577
650    _2
$a dieta s vysokým obsahem tuků $7 D059305
650    _2
$a dyslipidemie $x metabolismus $7 D050171
650    _2
$a ztučnělá játra $x metabolismus $7 D005234
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a glukosa $x metabolismus $7 D005947
650    _2
$a inzulin $x metabolismus $7 D007328
650    _2
$a inzulinová rezistence $7 D007333
650    _2
$a nitrobřišní tuk $x metabolismus $7 D050152
650    _2
$a metabolismus lipidů $x účinky léků $x fyziologie $7 D050356
650    _2
$a poruchy metabolismu lipidů $x etiologie $x patofyziologie $7 D052439
650    _2
$a lipidy $x krev $7 D008055
650    _2
$a lipogeneze $x účinky léků $7 D050155
650    _2
$a lipolýza $7 D008066
650    _2
$a játra $x metabolismus $7 D008099
650    _2
$a menopauza $x metabolismus $x fyziologie $7 D008593
650    _2
$a obezita $x metabolismus $7 D009765
650    _2
$a ovarektomie $x škodlivé účinky $7 D010052
650    _2
$a postmenopauza $x metabolismus $x fyziologie $7 D017698
650    _2
$a krysa rodu Rattus $7 D051381
650    _2
$a potkani Wistar $7 D017208
650    _2
$a triglyceridy $x metabolismus $7 D014280
650    _2
$a hmotnostní přírůstek $7 D015430
655    _2
$a časopisecké články $7 D016428
700    1_
$a Hüttl, Martina $u Centre for Experimental Medicine, Institute for Clinical and Experimental Medicine, 14021 Prague, Czech Republic
700    1_
$a Miklánková, Denisa $u Centre for Experimental Medicine, Institute for Clinical and Experimental Medicine, 14021 Prague, Czech Republic
700    1_
$a Trnovská, Jaroslava $u Centre for Experimental Medicine, Institute for Clinical and Experimental Medicine, 14021 Prague, Czech Republic
700    1_
$a Zapletalová, Iveta $u Department of Pharmacology, Faculty of Medicine and Dentistry, Palacky University, 77900 Olomouc, Czech Republic $7 xx0267200
700    1_
$a Poruba, Martin $u Department of Pharmacology, Faculty of Medicine and Dentistry, Palacky University, 77900 Olomouc, Czech Republic
700    1_
$a Marková, Irena $u Centre for Experimental Medicine, Institute for Clinical and Experimental Medicine, 14021 Prague, Czech Republic
773    0_
$w MED00176142 $t International journal of molecular sciences $x 1422-0067 $g Roč. 22, č. 9 (2021)
856    41
$u https://pubmed.ncbi.nlm.nih.gov/33926097 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20210728 $b ABA008
991    __
$a 20211207141613 $b ABA008
999    __
$a ok $b bmc $g 1689768 $s 1139228
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2021 $b 22 $c 9 $e 20210426 $i 1422-0067 $m International journal of molecular sciences $n Int J Mol Sci $x MED00176142
GRA    __
$a IKEM, IN 00023001 $p Ministry of Health of the Czech Republic under its conceptual development of research organisations programme
GRA    __
$a NU20-01-00083 $p Ministry of Health of the Czech Republic
GRA    __
$a IGA_LF_2021_013. $p Ministry of Health of the Czech Republic
LZP    __
$a Pubmed-20210728

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...